Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$639K Buy
34,749
+2,307
+7% +$49.3K ﹤0.01% 1233
2026
Q1
$656K Sell
32,442
-2,352
-7% -$52.3K 0.01% 1101
2025
Q4
$667K Buy
34,794
+7,086
+26% +$149K 0.01% 998
2025
Q3
$667K Sell
27,708
-1,534
-5% -$35.8K 0.01% 1032
2025
Q2
$569K Sell
29,242
-1,294
-4% -$19.1K 0.01% 972
2025
Q1
$393K Buy
30,536
+3,685
+14% +$59.2K 0.01% 1155
2024
Q4
$463K Buy
+26,851
New +$537K 0.01% 994

Other funds holding ADNT

Vident Advisory's ADNT Position: Q2 2026 in Review

Vident Advisory increased its Adient (ADNT) stake by 7.1% in Q2 2026, buying an estimated $49.3K and bringing the position to 34,749 shares worth $639K. The position accounts for ﹤0.01% of the portfolio, ranked #1233.

Vident Advisory first reported a position in ADNT in Q4 2024 and has held it in 7 quarters since. The position peaked at $667K in Q3 2025. 313 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • Vident Advisory held 34,749 shares of Adient worth $639K as of Q2 2026.
  • Vident Advisory bought 2,307 Adient shares in Q2 2026, an estimated $49.3K.
  • Adient made up ﹤0.01% of Vident Advisory's portfolio in Q2 2026, its #1233 holding.
  • Vident Advisory first reported a position in Adient in Q4 2024 and has held it in 7 quarters since.
  • Vident Advisory's Adient position peaked at $667K in Q3 2025.
  • 313 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.